Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP290989.RAXaNq2rX10mjRmRYeWg-snkTTfqKrLEgVyUrXkTD9q6A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP290989.RAXaNq2rX10mjRmRYeWg-snkTTfqKrLEgVyUrXkTD9q6A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP290989.RAXaNq2rX10mjRmRYeWg-snkTTfqKrLEgVyUrXkTD9q6A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP290989.RAXaNq2rX10mjRmRYeWg-snkTTfqKrLEgVyUrXkTD9q6A130_provenance.
- NP290989.RAXaNq2rX10mjRmRYeWg-snkTTfqKrLEgVyUrXkTD9q6A130_assertion description "[Because the humanized anti-CD20 antibody, rituximab, has antitumor activity in patients with PTLD and stimulates apoptosis in some lymphoid cell lines, we sought to determine whether Bcl-2 antisense treatment potentiates the antitumor effects of rituximab in EBV-associated lymphoproliferative disease in vitro and in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290989.RAXaNq2rX10mjRmRYeWg-snkTTfqKrLEgVyUrXkTD9q6A130_provenance.
- NP290989.RAXaNq2rX10mjRmRYeWg-snkTTfqKrLEgVyUrXkTD9q6A130_assertion evidence source_evidence_literature NP290989.RAXaNq2rX10mjRmRYeWg-snkTTfqKrLEgVyUrXkTD9q6A130_provenance.
- NP290989.RAXaNq2rX10mjRmRYeWg-snkTTfqKrLEgVyUrXkTD9q6A130_assertion SIO_000772 12738752 NP290989.RAXaNq2rX10mjRmRYeWg-snkTTfqKrLEgVyUrXkTD9q6A130_provenance.
- NP290989.RAXaNq2rX10mjRmRYeWg-snkTTfqKrLEgVyUrXkTD9q6A130_assertion wasDerivedFrom befree-20150227 NP290989.RAXaNq2rX10mjRmRYeWg-snkTTfqKrLEgVyUrXkTD9q6A130_provenance.
- NP290989.RAXaNq2rX10mjRmRYeWg-snkTTfqKrLEgVyUrXkTD9q6A130_assertion wasGeneratedBy ECO_0000203 NP290989.RAXaNq2rX10mjRmRYeWg-snkTTfqKrLEgVyUrXkTD9q6A130_provenance.
- befree-20150227 importedOn "2015-02-27" NP290989.RAXaNq2rX10mjRmRYeWg-snkTTfqKrLEgVyUrXkTD9q6A130_provenance.